Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Mitsunari

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Oncology Letters|March 31, 2017
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancerYasuyoshi Miyata, Kensuke Mitsunari, Asai Akihiro, et al.
Oncology Letters|March 31, 2017
Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survivalKensuke Mitsunari, Yasuyoshi Miyata, Shin-Ichi Watanabe, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 22, 2024
[Risk Factor of Cutaneous Symptoms Associated with Enfortumab Vedotin for Urothelial Carcinoma]Hiroyuki Honda, Tomohiro Matsuo, Shintaro Mori, et al.
IJU Case Reports|July 5, 2024
Initial experience of enfortumab vedotin in a patient with metastatic urothelial carcinoma on hemodialysis: Two case reportsShintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, et al.
International Journal of Clinical and Experimental Pathology|July 18, 2014
High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinomaKojiro Ohba, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 5, 2023
[Clinical Outcome of Surgical Resection for Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus]Hiromi Nakanishi, Kojiro Ohba, Yuichiro Nakamura, et al.
Medical Sciences (Basel, Switzerland)|October 14, 2020
Mechanisms Underlying the Inhibition of Tyrosine Kinase Inhibitor-Induced Anorexia and Fatigue by Royal Jelly in Renal Cell Carcinoma Patients and the Correlation between Macrophage Colony Stimulating Factor and Inflammatory MediatorsTsutomu Yuno, Yasuyoshi Miyata, Yuta Mukae, et al.
IJU Case Reports|February 23, 2026
Successful Treatment of Paranasal Sinus Metastasis From Renal Cell Carcinoma With Immune Checkpoint Inhibitors and Radiotherapy: A Case ReportShota Yamada, Tomohiro Matsuo, Ayaka Tsuchiyama, et al.
Urologia Internationalis|January 19, 2022
Alternative Treatment with Every-Other-Day Dosing of Sunitinib for Metastatic Renal Cell Carcinoma: Extended Follow-UpKojiro Ohba, Yasuyoshi Miyata, Kensuke Mitsunari, et al.
Molecules (Basel, Switzerland)|November 14, 2020
Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and PhotosensitizersYasuyoshi Miyata, Yuta Mukae, Junki Harada, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Oncology Letters|March 31, 2017
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancerYasuyoshi Miyata, Kensuke Mitsunari, Asai Akihiro, et al.
Oncology Letters|March 31, 2017
Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survivalKensuke Mitsunari, Yasuyoshi Miyata, Shin-Ichi Watanabe, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 22, 2024
[Risk Factor of Cutaneous Symptoms Associated with Enfortumab Vedotin for Urothelial Carcinoma]Hiroyuki Honda, Tomohiro Matsuo, Shintaro Mori, et al.
IJU Case Reports|July 5, 2024
Initial experience of enfortumab vedotin in a patient with metastatic urothelial carcinoma on hemodialysis: Two case reportsShintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, et al.
International Journal of Clinical and Experimental Pathology|July 18, 2014
High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinomaKojiro Ohba, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 5, 2023
[Clinical Outcome of Surgical Resection for Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus]Hiromi Nakanishi, Kojiro Ohba, Yuichiro Nakamura, et al.
Medical Sciences (Basel, Switzerland)|October 14, 2020
Mechanisms Underlying the Inhibition of Tyrosine Kinase Inhibitor-Induced Anorexia and Fatigue by Royal Jelly in Renal Cell Carcinoma Patients and the Correlation between Macrophage Colony Stimulating Factor and Inflammatory MediatorsTsutomu Yuno, Yasuyoshi Miyata, Yuta Mukae, et al.
IJU Case Reports|February 23, 2026
Successful Treatment of Paranasal Sinus Metastasis From Renal Cell Carcinoma With Immune Checkpoint Inhibitors and Radiotherapy: A Case ReportShota Yamada, Tomohiro Matsuo, Ayaka Tsuchiyama, et al.
Urologia Internationalis|January 19, 2022
Alternative Treatment with Every-Other-Day Dosing of Sunitinib for Metastatic Renal Cell Carcinoma: Extended Follow-UpKojiro Ohba, Yasuyoshi Miyata, Kensuke Mitsunari, et al.
Molecules (Basel, Switzerland)|November 14, 2020
Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and PhotosensitizersYasuyoshi Miyata, Yuta Mukae, Junki Harada, et al.
Pageof 9